New study maps out the timeline of DNA damage for multiple myeloma

A new study focused on multiple myeloma, the second most common blood cancer, may lead to better ways to group patients by the state of their DNA and define new subtypes of disease to better predict treatment strategies and outcomes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup